Prediction of adjuvant chemotherapy benefit in endocrine responsive, early breast cancer using multigene assays (Q35012951)

5 August 2017

1 reference

title

Prediction of adjuvant chemotherapy benefit in endocrine responsive, early breast cancer using multigene assays (English)

1 reference

5 August 2017

1 reference

1 reference

Soonmyung Paik

2

0 references

author name string

Kathy S Albain

series ordinal

1

1 reference

5 August 2017

Laura van't Veer

series ordinal

3

1 reference

5 August 2017

publication date

1 October 2009

1 reference

5 August 2017

1 reference

5 August 2017

volume

18 Suppl 3

1 reference

5 August 2017

page(s)

S141-5

1 reference

International Web-based consultation on priorities for translational breast cancer research

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970290-5

7 January 2021

Gene expression profiling of breast cancer: a new tumor marker

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970290-5

7 January 2021

Gene-expression signatures in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970290-5

7 January 2021

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970290-5

7 January 2021

A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970290-5

7 January 2021

A gene-expression signature as a predictor of survival in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970290-5

7 January 2021

Gene expression profiling predicts clinical outcome of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970290-5

7 January 2021

Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970290-5

7 January 2021

The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970290-5

7 January 2021

A five-gene molecular grade index and HOXB13:IL17BR are complementary prognostic factors in early stage breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970290-5

7 January 2021

Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970290-5

7 January 2021

Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970290-5

7 January 2021

The prognostic role of a gene signature from tumorigenic breast-cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970290-5

7 January 2021

A gene-expression signature to predict survival in breast cancer across independent data sets.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970290-5

7 January 2021

A consensus prognostic gene expression classifier for ER positive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970290-5

7 January 2021

An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970290-5

7 January 2021

Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970290-5

7 January 2021

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970290-5

7 January 2021

Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970290-5

7 January 2021

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970290-5

7 January 2021

Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970290-5

7 January 2021

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970290-5

7 January 2021

Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970290-5

7 January 2021

Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970290-5

7 January 2021

Impact of a Commercial Reference Laboratory Test Recurrence Score on Decision Making in Early-Stage Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970290-5

7 January 2021

Does oncotype DX recurrence score affect the management of patients with early-stage breast cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970290-5

7 January 2021

Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER).

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970290-5

7 January 2021

10.1016/S0960-9776(09)70290-5

Identifiers

DOI

1 reference

5 August 2017

1 reference